China National Accord Medicines Corp Ltd Total Liabilities

Latest as of September 2025: CN¥29.01 Billion CNY ≈ $4.24 Billion USD

China National Accord Medicines Corp Ltd total liabilities. Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has total liabilities worth CN¥29.01 Billion CNY (≈ $4.24 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000028 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of China National Accord Medicines Corp Ltd (1992–2024)

Total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2024. This chart illustrates how China National Accord Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore China National Accord Medicines Corp Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

China National Accord Medicines Corp Ltd Competitors by Total Liabilities

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their total liabilities.

Company Country Total Liabilities
Cetc Potevio Science&Technology Co Ltd
SHE:002544
China CN¥5.55 Billion
IGNITIS GRUPE AB EO 2233
F:IGV0
Germany €3.78 Billion
Dongguan Development Holdings Co Ltd
SHE:000828
China CN¥5.20 Billion
Eco World Develop Group
KLSE:8206
Malaysia RM7.37 Billion
Punjab & Sind Bank
NSE:PSB
India Rs1.67 Trillion
Ashtrom Group Ltd
TA:ASHG
Israel ILA18.15 Billion
J & J Snack Foods Corp
NASDAQ:JJSF
USA $463.81 Million
Hangzhou Kelin Electric Co. Ltd. A
SHG:688611
China CN¥208.95 Million

Liability Composition Analysis (1992–2024)

This chart breaks down China National Accord Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see China National Accord Medicines Corp Ltd total assets.

Liquidity & Leverage Metrics

China National Accord Medicines Corp Ltd Total Liabilities Ratios Explained

China National Accord Medicines Corp Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.50 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.57 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how China National Accord Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for China National Accord Medicines Corp Ltd (1992–2024)

The table below shows the annual total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥26.80 Billion
≈ $3.92 Billion
+0.78%
2023-12-31 CN¥26.59 Billion
≈ $3.89 Billion
+14.77%
2022-12-31 CN¥23.17 Billion
≈ $3.39 Billion
-6.42%
2021-12-31 CN¥24.76 Billion
≈ $3.62 Billion
+9.05%
2020-12-31 CN¥22.71 Billion
≈ $3.32 Billion
+25.03%
2019-12-31 CN¥18.16 Billion
≈ $2.66 Billion
+20.87%
2018-12-31 CN¥15.02 Billion
≈ $2.20 Billion
+21.01%
2017-12-31 CN¥12.42 Billion
≈ $1.82 Billion
+0.14%
2016-12-31 CN¥12.40 Billion
≈ $1.81 Billion
+62.04%
2015-12-31 CN¥7.65 Billion
≈ $1.12 Billion
-4.08%
2014-12-31 CN¥7.98 Billion
≈ $1.17 Billion
-8.73%
2013-12-31 CN¥8.74 Billion
≈ $1.28 Billion
+17.23%
2012-12-31 CN¥7.46 Billion
≈ $1.09 Billion
+19.52%
2011-12-31 CN¥6.24 Billion
≈ $912.96 Million
+20.55%
2010-12-31 CN¥5.18 Billion
≈ $757.32 Million
+18.83%
2009-12-31 CN¥4.36 Billion
≈ $637.33 Million
+43.52%
2008-12-31 CN¥3.03 Billion
≈ $444.06 Million
+27.05%
2007-12-31 CN¥2.39 Billion
≈ $349.51 Million
+8.26%
2006-12-31 CN¥2.21 Billion
≈ $322.86 Million
+225.07%
2005-12-31 CN¥678.73 Million
≈ $99.32 Million
+39.09%
2004-12-31 CN¥487.99 Million
≈ $71.41 Million
-26.67%
2003-12-31 CN¥665.47 Million
≈ $97.38 Million
-7.30%
2002-12-31 CN¥717.90 Million
≈ $105.05 Million
-4.75%
2001-12-31 CN¥753.72 Million
≈ $110.29 Million
+778.18%
2000-12-31 CN¥85.83 Million
≈ $12.56 Million
-1.03%
1999-12-31 CN¥86.72 Million
≈ $12.69 Million
-24.01%
1998-12-31 CN¥114.11 Million
≈ $16.70 Million
-31.94%
1997-12-31 CN¥167.66 Million
≈ $24.53 Million
+87.37%
1996-12-31 CN¥89.48 Million
≈ $13.09 Million
+77.00%
1995-12-31 CN¥50.55 Million
≈ $7.40 Million
-11.09%
1994-12-31 CN¥56.85 Million
≈ $8.32 Million
-41.32%
1993-12-31 CN¥96.88 Million
≈ $14.18 Million
+4.01%
1992-12-31 CN¥93.14 Million
≈ $13.63 Million
--

About China National Accord Medicines Corp Ltd

SHE:000028 China Medical Distribution
Market Cap
$1.53 Billion
CN¥10.43 Billion CNY
Market Cap Rank
#6937 Global
#1427 in China
Share Price
CN¥21.50
Change (1 day)
-0.78%
52-Week Range
CN¥18.91 - CN¥27.00
All Time High
CN¥2829.45
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more